2.34
-0.14(-5.65%)
Currency In USD
| Previous Close | 2.48 |
| Open | 2.4 |
| Day High | 2.43 |
| Day Low | 2.33 |
| 52-Week High | 3.38 |
| 52-Week Low | 0.82 |
| Volume | 1.36M |
| Average Volume | 2.6M |
| Market Cap | 85.12M |
| PE | -3.66 |
| EPS | -0.64 |
| Moving Average 50 Days | 2.41 |
| Moving Average 200 Days | 1.57 |
| Change | -0.14 |
If you invested $1000 in Microbot Medical Inc. (MBOT) 10 years ago, it would be worth $2.06 as of June 15, 2025 at a share price of $2.34. Whereas If you bought $1000 worth of Microbot Medical Inc. (MBOT) shares 5 years ago, it would be worth $339.13 as of June 15, 2025 at a share price of $2.34.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
GlobeNewswire Inc.
Jun 09, 2025 12:30 PM GMT
The addition of the head of Sales Operations & Analytics aims to strengthen sales infrastructure and launch executionHINGHAM, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY Endovas
Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index
GlobeNewswire Inc.
Jun 05, 2025 12:30 PM GMT
HINGHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, announced that it has been selected for inclusion in the preliminary list of additions to the
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers
GlobeNewswire Inc.
Apr 23, 2025 12:30 PM GMT
The addition of a seasoned VP of Marketing compliments the recent hiring of the Company’s VP of Sales to establish its commercialization readiness infrastructure Positive data from the recently published pivotal study raises confidence that LIBERTY®